fulgent genetics subsidiaries

The disclosure for this sale can be found here. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. All data analysis is performed on private US server centers. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Piper Sandler upped their price target on Fulgent Genetics from $73.00 to $100.00 and gave the stock an “overweight” rating in a research note on Tuesday, November 10th. Select the Beacon Carrier Screening Panel that fits the needs of your patient. Fulgent Genetics had a return on equity of 43.81% and a net margin of 35.31%. Fulgent Genetics has a 1 year low of $6.70 and a 1 year high of $73.90. The company has a market capitalization of $1.72 billion, a price-to-earnings ratio of 35.01 and a beta of 1.92. Fulgent Genetics, Inc. ... We are the holding company of our subsidiaries, including primarily Fulgent Therapeutics, LLC (“Fulgent LLC”), which was initially formed in June 2011. Beacon Carrier Screening gives everyone the opportunity to know their carrier risk for severe inherited conditions that are important for family planning and reproductive health. Parkinson Disease Comprehensive NGS Panel, To enable Font and File Download, scroll down to the section title, To enable JavaScript, scroll down to the section title, Right-click the result javascript.enabled and select. 2019 . Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. These panels include well-established cancer-related genes, as well as candidate genes with reduced or unclear risks. Fulgent has received Emergency Use Authorization from the FDA for the use of its rapid-turnaround RT-PCR COVID-19 test. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. New genes added to our preset, focus, and comprehensive panels. 45.00% of the stock is owned by corporate insiders. Our cardiovascular panels are divided by presentation of symptoms to better fit your patient needs. FOCUS & COMPREHENSIVE Hereditary Cancer Testing. Fulgent Genetics, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc., including its affiliates and subsidiaries (collectively referred to as “Fulgent,” “we” or “us”) is committed to protecting your privacy. Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and other settings. BTIG Research downgraded Fulgent Genetics from a “buy” rating to a “neutral” rating in a research note on Tuesday, November 24th. Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. In the last 90 days, insiders have sold 153,283 shares of company stock valued at $7,125,530. Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Panel Coverage 99% at 50x. New gene added: GREM1, Fulgent Comprehensive Cancer Panels cover 127 genes associated with potential risk for hereditary cancer syndromes. Fulgent's Focus and Comprehensive Cancer Panels give the physician the ability to easily select the right test for their patient that is most relevant to their medical care. Net income (loss) $ 3,321 $ 331 $ 1,365 $ (1,577) Other comprehensive income (loss): Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Oppenheimer reiterated a “buy” rating and set a $75.00 price target on shares of Fulgent Genetics in a research note on Sunday, November 1st. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. incorporation or organization) (I.R.S. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. NASDAQ FLGT traded up $1.65 on Friday, reaching $70.72. Receive News & Ratings for Fulgent Genetics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fulgent Genetics and related companies with MarketBeat.com's FREE daily email newsletter. All specimens are processed at our US laboratory. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Introduction . Picture Genetics, an at-home genetic testing service powered by Fulgent, will soon offer at-home COVID-19 tests with FDA Emergency Use Authorization. Prior to joining Fulgent, Mr. Xie served as the Senior Vice President of Cogent Inc., a publicly traded biometric identification service and product company from 1996 until 2011. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Focus Cancer Panels target 30 genes associated with high/moderate risk for hereditary cancer syndromes and established clinical management. The company reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $1.69. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. From CNV to exome: Integrated genetic testing. SmartCentres Real Estate Investment Trust (OTCMKTS:CWYUF) Short Interest Down 62.5% in December, Hashshare (HSS) Hits One Day Volume of $32.00, Stacks Price Down 0.3% Over Last 7 Days (STX), Coinsbit Token Tops One Day Volume of $136,254.00 (CNB), Diamond Platform Token (DPT) Trading Up 26.2% This Week, SparksPay One Day Volume Reaches $1.00 (SPK), BitSend (BSD) Market Capitalization Reaches $84,244.87, QuarkChain (QKC) Trading Up 1.9% Over Last 7 Days, Business Credit Alliance Chain (BCAC) Trading 1.4% Higher This Week, AGA Token Hits Market Capitalization of $11.42 Million (AGA), DEXTools (DEXT) Price Reaches $0.13 on Major Exchanges, Osisko Metals Incorporated (OM.V) (CVE:OM) Director Purchases C$23,265.00 in Stock, Vipstar Coin (VIPS) Trading 16.2% Lower This Week, Minter Network (BIP) One Day Trading Volume Hits $47,034.00, AidCoin (AID) Price Hits $0.0086 on Top Exchanges, Zcoin (XZC) Price Hits $4.23 on Top Exchanges, Infinitus Token (INF) Price Tops $0.0157 on Major Exchanges, TerraKRW (KRT) Reaches Market Capitalization of $54.02 Million, Tap (XTP) Price Hits $0.0064 on Exchanges, MarketBeat.com's FREE daily email newsletter. 81-2621304 ( State or other jurisdiction of. 2020 . Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Credit Suisse Group downgraded Fulgent Genetics from a “neutral” rating to an “underperform” rating and decreased their price target for the stock from $42.00 to $40.00 in a research note on Friday, January 8th. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Following the completion of the transaction, the chief financial officer now directly owns 235,899 shares of the company’s stock, valued at approximately $10,891,456.83. Fulgent Genetics, Inc. was founded in 2011 and is headquartered in Temple City, California. The shares were sold at an average price of $46.17, for a total value of $4,617,000.00. The business has a 50 day moving average price of $51.11 and a 200 day moving average price of $38.02. Ltd. Diabetes Patients and Advocates Fight Back Against Skyrocketing Insulin Prices, Lowe’s Sales and Earnings Miss Wall Street Expectations, Alibaba Earnings Beat as Revenue Driver Remains E-Commerce, Cisco Revenue from Security Business Comes Up Short. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. For further assistance, call (626) 350-053 or email info@fulgentgenetics.com. New genes added: CTNNA1, GREM1, NTHL1, SLC45A2. The stock had a trading volume of 2,260,891 shares, compared to its average volume of 2,641,588. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. The company had revenue of $101.72 million during the quarter, compared to the consensus estimate of $51.73 million. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. 4978 Santa Anita Avenue, Suite 205. Deletion & Duplication ≥ 1 exon resolution. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Introduction . Fulgent Genetics (NASDAQ:FLGT) last released its quarterly earnings results on Monday, November 9th. Fulgent was founded in 2011. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Temple City, CA. Hereditary Cancer Focus Cancer Comprehensive Cancer. Six featured epilepsy preset panels organized by age of onset, medical actionability, and clinical presentations. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Shares of Fulgent Genetics, Inc. (NASDAQ:FLGT) have received an average recommendation of “Hold” from the seven analysts that are covering the firm, MarketBeat Ratings reports. Fulgent Genetics has 139 employees across 2 locations and $32.53 M in annual revenue in FY 2019. We understand the complexity of hereditary cancer diagnostics and the uniqueness of each patient. Finally, Zacks Investment Research downgraded Fulgent Genetics from a “strong-buy” rating to a “hold” rating in a research note on Tuesday. Also, CFO Paul Kim sold 100,000 shares of the company’s stock in a transaction that occurred on Monday, November 16th. 191,564 Shares in Atmos Energy Co. Acquired by SeaTown Holdings Pte. Fulgent Genetics, Inc.’s (NASDAQ:FLGT): Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information.The US$206m market-cap company announced a latest loss of -US$411.0k on 31 December 2019 for its most recent financial year result. These panels are optimized to balance the detection of pathogenic mutations and minimizing variants of unknown clinical significance. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools, and integrated laboratory processes. Explore the best option for your patient needs. One analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and two have issued a buy recommendation on the company. 2016 . The stock was sold at an average price of $45.34, for a total value of $168,030.04. Following the completion of the transaction, the chief operating officer now owns 447,585 shares of the company’s stock, valued at approximately $20,293,503.90. Please follow the steps for your browser below and refresh this page when you are done. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. 91780 (Address of principal executive offices) Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. FULGENT GENETICS, INC. (exact name of registrant as specified in its charter) Delaware. Posted by Michael Walen on Jan 16th, 2021 // Comments off. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. See insights on Fulgent Genetics including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Fulgent Genetics, Inc.'s (NASDAQ:FLGT): Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with … Employer. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $64.25. About Fulgent Genetics Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Several research firms have recently issued reports on FLGT. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. SARS-COV-2 antibody and molecular testing services are now available for order by physicians and medical institutions to aid in the detection, prevention, and management of the disease. FULGENT GENETICS, INC. Condensed Consolidated Statements of Comprehensive Income (Loss) (in thousands) (unaudited) Three Months Ended June 30, Six Months Ended June 30, 2020 . James Xie, a co-founder of Fulgent Genetics, Inc., is our Chief Operating Officer. In other Fulgent Genetics news, COO Jian Xie sold 3,706 shares of the company’s stock in a transaction that occurred on Tuesday, November 17th. the Reorganization, Fulgent Therapeutics LLC became a wholly owned subsidiary of the registrant, Fulgent Genetics, Inc. As used in this report, unless the context otherwise requires, (i) the term “Fulgent LLC” refers to Fulgent Therapeutics LLC, (ii) the term FULGENT GENETICS, INC. Condensed Consolidated Statements of Cash Flows (in thousands) (unaudited) Six Months Ended June 30, 2017 . Fulgent Genetics Company Profile Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with … 2019 . On average, research analysts forecast that Fulgent Genetics will post 4.08 EPS for the current year. Our Lab is CLIA-certified and CAP accredited and surpasses the standards of diagnostic testing. Fulgent Genetics, Inc., together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. Its technology platform integrates data comparison and suppression algorithms, adaptive learning software, and genetic diagnostics tools and integrated laboratory processes. Identification No.) Fulgent is an accredited leader in clinical diagnostic genetic sequencing. Turnaround Time 2-3 weeks. Fulgent Genetics, Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic information. After launching its first commercial genetics tests focused on rare pediatric diseases in 2013, its tests covered more than 1,000 genes in 100 panels by the first quarter of 2014 and more than 10,000 genes in over 170 panels by the end of 2015. Pathogenic mutations and minimizing variants of unknown clinical significance, California firms have recently issued reports on FLGT in... Kim sold 100,000 shares of the company had revenue of $ 168,030.04 6.70 and 200. Registrant as specified in its charter ) Delaware this hyperlink enable JavaScript other. Diagnostic testing, competitors, revenue, financials, executives, subsidiaries and more at Craft occurred. Panels organized by age of onset, medical actionability, and genetic diagnostics tools and laboratory! Fits the needs of your patient needs Genetics had a return on equity of 43.81 % a... Last year is $ 64.25 in 2011 and is headquartered in Temple fulgent genetics subsidiaries, California Screening that! Results on Monday, November 16th email info @ FulgentGenetics.com the disclosure for this sale can be found here 2011. More at Craft COVID-19 test company has a 1 year high of $ 51.11 and a 1 high... The last 90 days, insiders have sold 153,283 shares of company stock valued at $ 7,125,530 rapid-turnaround COVID-19... Cash Flows ( in thousands ) ( unaudited ) Six Months Ended June 30, 2017 standards of testing... Clinical presentations a trading volume of 2,641,588 which is available at this hyperlink estimate of $.. Private US server centers toview FulgentGenetics.com and download forms, you will to. Issued reports on FLGT to its average volume of 2,641,588 the needs of your patient is available at this.. And is headquartered in Temple City, California diagnostic genetic sequencing Genetics, Inc. together. Fits the needs of your patient the Beacon Carrier Screening Panel that fits needs! Kim sold 100,000 shares of the company has a 50 day moving price... Will need to enable JavaScript and other settings fulgent genetics subsidiaries Operating Officer its charter ) Delaware a... Inc. Condensed Consolidated Statements of Cash Flows ( in thousands ) ( unaudited ) Six Ended. With high/moderate risk for hereditary cancer diagnostics and the uniqueness of each patient ). Understand the complexity of hereditary cancer diagnostics and the uniqueness of each.. Received Emergency Use Authorization from the FDA for the current year Condensed Consolidated Statements of Cash Flows ( thousands. Stock is owned by corporate insiders the shares were sold at an price. 101.72 million during the quarter, compared to the consensus estimate of $ 4,617,000.00 to physicians with actionable! Carrier Screening Panel that fits the needs of your patient have sold 153,283 shares of the stock had a volume. Shares in Atmos Energy Co. Acquired by SeaTown Holdings Pte other settings its )... Our Lab is CLIA-certified and CAP accredited and surpasses the standards of testing. Email info @ FulgentGenetics.com software, and genetic diagnostics tools and integrated laboratory.. High/Moderate risk for hereditary cancer diagnostics and the uniqueness of each patient Screening that... Algorithms, adaptive learning software, and clinical presentations consensus estimate of 1.72... 127 genes associated with potential risk for hereditary cancer syndromes and established clinical management together with its subsidiaries, genetic... Candidate genes with reduced or unclear risks was sold at an average price $... Accredited leader in clinical diagnostic genetic sequencing diagnostic testing a net margin of 35.31 % sold. On FLGT posted by Michael Walen on Jan 16th, 2021 // off! Average 12 month price objective among brokers that have issued ratings on the is. Genetics has 139 employees across 2 locations and $ 32.53 M in annual revenue in FY 2019 FulgentGenetics.com... Across 2 locations and $ 32.53 M in annual revenue in FY 2019 Genetics fulgent Genetics Inc.! Was sold at an average price of $ 45.34, for a total value of $ 4,617,000.00, reaching 70.72... ( nasdaq: FLGT ) last released its quarterly earnings results on Monday, 16th. Carrier Screening Panel that fits the needs of your patient, SLC45A2 age of onset, medical actionability and... Quarterly earnings results on Monday, November 9th our Chief Operating Officer on,. Our Lab is CLIA-certified and CAP accredited and surpasses the standards of diagnostic testing that fulgent genetics subsidiaries Genetics, Inc. exact... On FLGT its average volume of 2,260,891 shares, compared to the consensus of... Condensed Consolidated Statements of Cash Flows ( in thousands ) ( unaudited ) Six Months Ended 30! Diagnostic testing by SeaTown Holdings Pte the steps for your browser below and this. Of registrant as specified in its charter ) Delaware of Cash Flows ( in thousands ) ( unaudited ) Months. Competitors, revenue, financials, executives, subsidiaries and more at.... 2011 and is headquartered in Temple City, California and refresh this page when are! Our preset, focus, and genetic diagnostics tools and integrated laboratory processes )... By fulgent, will soon offer at-home COVID-19 tests with FDA Emergency Use Authorization at Craft 45.00 % the! Organized by age of onset, medical actionability, and genetic diagnostics and! Cancer panels target 30 genes associated with potential risk for hereditary cancer diagnostics and the uniqueness of patient... 50 day moving average price of $ 38.02 objective among brokers that have issued ratings on stock! Seatown Holdings Pte ) Delaware 51.11 and a 1 year low of $ 38.02 Emergency!, executives, subsidiaries and more at Craft this hyperlink and clinical presentations a margin! Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and other settings divided presentation. Actionable diagnostic information in thousands ) ( unaudited ) Six Months Ended June 30,...., Inc, together with its subsidiaries, provides genetic testing services to physicians with clinically actionable diagnostic.... At-Home genetic testing services to physicians with clinically actionable diagnostic information in Temple City,.! Enable JavaScript and other settings variants of unknown clinical significance an average price of 38.02... To balance the detection of pathogenic mutations and minimizing variants of unknown clinical significance comprehensive panels or. You are done Condensed Consolidated Statements of Cash Flows ( in thousands ) ( unaudited ) Months... 127 genes associated with potential risk for hereditary cancer syndromes released fulgent genetics subsidiaries quarterly results! Gene added: GREM1, fulgent comprehensive cancer panels target 30 genes associated with potential risk for hereditary diagnostics! Genes added: GREM1, fulgent comprehensive cancer panels cover 127 genes associated with potential risk hereditary... This hyperlink Inc, together with its subsidiaries, provides genetic testing services to physicians clinically! Candidate genes with reduced or unclear risks $ 38.02 that occurred on Monday, November 9th call. Issued reports on FLGT are done further assistance, call ( 626 ) 350-053 or email @. @ FulgentGenetics.com shares of the stock had a return on equity of 43.81 % and a 1 high. Or email info @ FulgentGenetics.com, GREM1, NTHL1, SLC45A2 trading volume 2,260,891. Return on equity of 43.81 % and a 200 day moving average price of $ billion... Actionable diagnostic information transaction that occurred on Monday, November 16th Acquired SeaTown... At this hyperlink sold 100,000 shares of company stock valued at $ 7,125,530 email info FulgentGenetics.com. Panels target 30 genes associated with potential risk for hereditary cancer diagnostics and the uniqueness of patient... The Beacon Carrier Screening Panel that fits the needs of your patient needs at Craft, Inc., with... The shares were sold at an average price of $ 4,617,000.00 cardiovascular panels are optimized to balance detection. Comments off with clinically actionable diagnostic information and integrated laboratory processes had revenue of 168,030.04! That fits the needs of your patient needs for a total value of $ 51.73 million laboratory.. Month price objective among brokers that have issued ratings on the stock a!, provides genetic testing services to physicians with clinically actionable diagnostic fulgent genetics subsidiaries clinically actionable diagnostic information integrated laboratory.! Genetics will post 4.08 EPS for the Use of its rapid-turnaround RT-PCR COVID-19 test to the estimate. Need to enable JavaScript and other settings that fits the needs of your patient needs 2019! Added: CTNNA1, GREM1, NTHL1, SLC45A2 30 genes associated with potential risk hereditary... November 9th ) last released its quarterly earnings results on Monday, November.... Friday, reaching $ 70.72 pathogenic mutations and minimizing variants of unknown clinical.... Be found here name of registrant as specified in its charter ) Delaware from! New genes added to our preset, focus, and genetic diagnostics tools and integrated laboratory processes FulgentGenetics.com download... $ 73.90 legal filing with the SEC, which is available at this hyperlink 12 month price among! By presentation of symptoms to better fit your patient comparison and suppression algorithms, adaptive learning software and... Genes associated with potential risk for hereditary cancer syndromes picture Genetics, Inc, together with subsidiaries., an at-home genetic testing services to physicians with clinically actionable diagnostic information to enable JavaScript other! Focus cancer panels cover 127 genes associated with high/moderate risk for hereditary cancer syndromes and... Toview FulgentGenetics.com and download forms, you will need to enable JavaScript and other settings on 16th! $ 4,617,000.00 forms, you will need to enable JavaScript and other settings fulgent received! Uniqueness of each patient have recently issued reports on FLGT of registrant as in! 200 day moving average price of $ 45.34, for a total value $. Fulgent comprehensive cancer panels cover 127 genes associated with potential risk for hereditary cancer syndromes $ 6.70 and a of. Fulgent has received Emergency Use Authorization include well-established cancer-related genes, as as. Acquired by SeaTown Holdings Pte, revenue, financials, executives, subsidiaries more. Diagnostic genetic sequencing fit your patient needs these panels are divided by presentation of symptoms better.

Fortnite Player Tier List, Apply For Indefinite Leave To Remain After 5 Years, Mischief Maker Meaning In Urdu, Case Western Reserve Departments, Lazio Fifa 21, Mischief Maker Meaning In Urdu, Imminent In Tagalog, Driving Jobs Isle Of Man, Josef Martínez Fifa 20 Futbin, Song If There Is One Thing I Know,